Skip to main content
Clinical Trials/NCT03388671
NCT03388671
Unknown
Phase 2

Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery.

Assiut University1 site in 1 country44 target enrollmentDecember 25, 2017

Overview

Phase
Phase 2
Intervention
TAB Block
Conditions
Analgesia
Sponsor
Assiut University
Enrollment
44
Locations
1
Primary Endpoint
FLACC PAIN score
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study will be to investigate the safety and analgesic efficacy of Transversus Abdominis Plane (TAB) Block versus psoas block blockade. Both blocks will be administered surgically and guided by the laparoscopy screen in children undergoing laparoscopic surgery.

Detailed Description

Transversus abdominis plane (TAP) block is a promising effective method for postoperative pain control after major abdominal surgery. TAP block provides analgesia by inhibiting nerve conduction from the anterior abdominal wall arising from the intercostal nerves, subcostal nerves, and first lumbar nerve (T6-L1). Using a landmark technique, it is easily performed, but its popularity has decreased because of reduced efficacy due to inaccurate injection and the potential for intra-peritoneal organ damage. Ultrasound-guided TAP block provides better results and fewer complications, but it requires experienced operators. Surgically administered TAP (sTAP) block guided by the video camera of the laparoscope is a simple technique and may cause no complications. Also, under laparoscopic guidance, block of ilioinguinal, iliohypogastric, and genitofemoral nerves can be possible with anesthetic injection in the plane between psoas major and the fasciae covering its anterior aspects \[laparoscopic-assisted psoas (LAP) blockade\].

Registry
clinicaltrials.gov
Start Date
December 25, 2017
End Date
December 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hala Saad Abdel-Ghaffar

principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Children (1-6 years) of both sexes undergoing elective laparoscopic surgeries that last \>30minutes (eg. undescended testis and inguinal hernia repair).
  • Written consent, free and informed

Exclusion Criteria

  • Significant respiratory, cardiac or renal disease
  • BMI \>95th percentile for age.

Arms & Interventions

TAB Block

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Transversus abdominis plane block.

Intervention: TAB Block

TAB Block

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided Transversus abdominis plane block.

Intervention: Bupivacaine

Psoas Block

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided psoas block.

Intervention: Psoas Block

Psoas Block

Patients will recieve 0.3ml/kg bupivacaine 0.25% on each side for laparoscopically guided psoas block.

Intervention: Bupivacaine

Outcomes

Primary Outcomes

FLACC PAIN score

Time Frame: 36hours

postoperative FLACC pain scores.

Study Sites (1)

Loading locations...

Similar Trials